Plate fixation vs. intramedullary nailing: Which is more cost-effective for tibial shaft fractures? Authors: Seyed Houssien Saeed-Banadaky, Mehdi Raadabadi, Amir Mohammad Sotoudehnia, Rajabali Daroudi, Seyed Masoud Mousavi, Mohammad Ranjbar Published: 2026 ABSTRACT AbstractIntroductionTibial shaft fractures are among the most common injuries resulting from trauma and are typically managed surgically via either plate fixation or intramedullary nailing. Given the constraints on healthcare resources and the imperative to control costs, evaluating the cost-effectiveness of these treatment strategies is essential. This study aimed to assess and compare the cost-effectiveness of intramedullary nailing versus plate fixation for tibial shaft fractures.MethodsThis cross-sectional economic evaluation was conducted from a modified societal perspective, incorporating direct medical costs (from hospital records and patient reports) and direct non-medical costs (from patient reports), alongside treatment effectiveness measured by health-related quality of life (HRQoL) and QALYs. The study included 276 patients with mid-shaft tibial fractures treated surgically with either intramedullary nailing or plate fixation at Shahid Dr. Rahnemoon Hospital, Yazd, Iran. Patients were followed for three months post-discharge. A willingness-to-pay (WTP) threshold of USD 4,771.4 per QALY (based on Iran’s 2024 GDP per capita) was applied, and cost-effectiveness analysis was performed using Stata version 16 and TreeAge Pro 2020.ResultsThe mean total direct cost per patient was lower for intramedullary nailing (USD 602.87) than plate fixation (USD 669.68), with hospital expenses comprising the largest share (USD 448.47 vs. USD 472.84, respectively). Using a linear area-under-the-curve approach, accumulated QALYs over 90 days were higher for nailing (0.0627) than plate fixation (0.0448). Cost-effectiveness analysis identified intramedullary nailing as the undominated strategy, while plate fixation was absolutely dominated due to higher costs and lower effectiveness. Probabilistic sensitivity analysis, cost-effectiveness acceptability curves, and one-way sensitivity analyses consistently supported the cost-effectiveness advantage of intramedullary nailing under uncertainty at a willingness-to-pay threshold of USD 4,771.4 per QALY.ConclusionThis short-term economic evaluation indicates that intramedullary nailing is an undominated and more cost-effective option than plate fixation for the surgical management of tibial shaft fractures over a 90-day follow-up period, providing higher accumulated QALYs at lower direct costs. These findings support the preferential use of intramedullary nailing in similar clinical settings; however, longer-term studies incorporating fracture healing, complications, and indirect costs are needed to confirm cost-effectiveness beyond the early postoperative period.Keywords: Intramedullary nailing, Plate fixation, Cost-effectiveness, Tibial shaft fracture, Quality of life Introduction Traumatic injuries remain a major global public health challenge [1]. Worldwide, they are among the top four causes of death across all age groups and represent the leading cause of mortality among individuals under 45 years of age [2], accounting for approximately 10% of all global deaths [3]. In Iran, between 2005 and 2015, road traffic accidents and trauma ranked just after ischemic heart disease and stroke as the most common causes of death. Notably, while traffic accidents were the second leading cause of death in 2005, they continued to account for substantial premature mortality in subsequent years, ranking second only to heart disease in terms of years of life lost [4]. Beyond their human toll, traumatic injuries impose significant social and economic burdens, affecting not only patients and their families but also the broader healthcare system [5]. Globally, it is estimated that trauma-related injuries account for nearly 3% of the world’s gross domestic product (GDP) each year [6]. The broader economic impact—including lost productivity, human costs, and healthcare services—has been estimated to consume roughly 1% of GDP in low-income countries, 1.5% in middle-income countries, and 2% in high-income countries [7]. Among the most common injuries associated with trauma, especially traffic accidents, are fractures of the lower extremities—most notably the tibia [8]. The tibia, along with the fibula, forms the lower leg, bearing the majority of body weight and playing a critical role in movement and stability [9]. The incidence of tibial shaft fractures is approximately 17 per 100,000 person-years [10]. These injuries account for about 2% of all fractures and 37% of long bone fractures in adults [11]. Due to the need for complex care and rehabilitation, tibial fractures are associated with high healthcare costs, potentially creating a significant economic burden on society [12]. While non-displaced or stable fractures can often be managed conservatively through casting and physiotherapy [13], displaced or complex fractures typically require surgical intervention to restore alignment and function [13]. However, limited blood supply in the tibial shaft increases the risk of complications such as nonunion, malunion, and infection [11, 14]. Two surgical techniques are most commonly employed: plate fixation and intramedullary nailing [15, 16]. Plate fixation involves attaching a metal plate to the outer surface of the bone using screws [17], whereas intramedullary nailing uses a metal rod inserted into the medullary canal, secured with interlocking screws [18]. While numerous studies have highlighted the clinical advantages of intramedullary nailing over alternative techniques [19–26], the choice between these two methods remains debated [27]. Previous research has compared their outcomes in terms of union rates, infection, pain, and soft tissue complications [28, 29]. However, given limited healthcare resources and growing emphasis on cost containment, evaluating their cost-effectiveness is crucial. A review of the literature revealed no prior cost-effectiveness analysis comparing these two methods specifically for tibial shaft fractures in Iran. Only two international studies—in the UK [30] and Turkey [16]—were identified, but neither focused exclusively on cost-effectiveness for shaft fractures. Therefore, the present study aims to fill this gap by comparing the cost-effectiveness of intramedullary nailing versus plate fixation for tibial shaft fractures, offering evidence to inform healthcare resource allocation and policy decisions. Methods Study design and setting This study is a cross-sectional economic evaluation conducted from a modified societal perspective, incorporating direct medical costs (captured from hospital records and patient reports) and direct non-medical costs (captured from patient reports), alongside treatment effectiveness measured by health-related quality of life (HRQoL) and QALYs. The research was conducted at the Orthopedic Department of Shahid Dr. Rahnemoon Hospital, a major referral center for trauma care in central, southern, and southeastern Iran. This study adheres to the CHEERS 2022 reporting guideline, and the completed checklist is available as Supplementary File 1. Time horizon The time horizon of this economic evaluation was 90 days, starting from the day of surgery (day 0) and ending at the third postoperative month (day 90). This short‑term horizon was chosen to capture the early postoperative recovery phase, including hospital stay and the initial period of functional restoration. Study population The target population included adult patients (≥ 18 years) with closed mid-shaft tibial fractures who underwent surgical treatment with either plate fixation or intramedullary nailing. Data were collected over a nine-month period from March 21, 2024, to December 21, 2024. A consecutive sampling approach was used to include all eligible patients, ensuring comprehensive case capture and minimizing selection bias. Inclusion criteria Age 18 years or older Age 18 years or older Closed mid-shaft tibial fracture Closed mid-shaft tibial fracture Intact neurovascular status of the affected leg Intact neurovascular status of the affected leg Exclusion criteria Open or complex fractures Open or complex fractures Polytrauma or associated injuries Polytrauma or associated injuries Fractures extending into the knee or ankle joint Fractures extending into the knee or ankle joint Contraindications to anesthesia or either surgical technique Contraindications to anesthesia or either surgical technique Inability or unwillingness to complete study questionnaires Inability or unwillingness to complete study questionnaires Bilateral tibial fractures Bilateral tibial fractures Data collection Data were gathered using two primary tools: A researcher-designed form for demographic and clinical variables, including age, sex, height, weight, smoking status, comorbidities, and hospital length of stay. A researcher-designed form for demographic and clinical variables, including age, sex, height, weight, smoking status, comorbidities, and hospital length of stay. The EQ-5D-5L questionnaire to assess health-related quality of life (HRQoL). The EQ-5D-5L instrument comprises five dimensions—mobility, self-care, usual activities, pain/discomfort, and anxiety/depression—each with five response levels, generating a five-digit health state code (23,24). Additionally, patients rated their overall health on a Visual Analogue Scale (VAS) ranging from 0 (worst imaginable health) to 100 (best imaginable health) (25). The EQ-5D-5L questionnaire to assess health-related quality of life (HRQoL). The EQ-5D-5L instrument comprises five dimensions—mobility, self-care, usual activities, pain/discomfort, and anxiety/depression—each with five response levels, generating a five-digit health state code (23,24). Additionally, patients rated their overall health on a Visual Analogue Scale (VAS) ranging from 0 (worst imaginable health) to 100 (best imaginable health) (25). Cost data were obtained from two sources to capture both direct medical and non-medical expenses from a modified societal perspective. Direct medical costs—including surgery, hospitalization, medication, medical equipment and supplies, outpatient visits, home care, and other hospital-based services—were extracted from the Hospital Information System (HIS), patient medical records, and structured interviews at three follow-up time points: one week, six weeks, and three months post-treatment. Direct non-medical costs, such as travel, accommodation, and caregiver expenses, were also collected through patient interviews at the same intervals. Cost data were obtained from two sources to capture both direct medical and non-medical expenses from a modified societal perspective. Direct medical costs—including surgery, hospitalization, medication, medical equipment and supplies, outpatient visits, home care, and other hospital-based services—were extracted from the Hospital Information System (HIS), patient medical records, and structured interviews at three follow-up time points: one week, six weeks, and three months post-treatment. Direct non-medical costs, such as travel, accommodation, and caregiver expenses, were also collected through patient interviews at the same intervals. Comparisons of baseline demographic and clinical characteristics between the plate fixation and intramedullary nailing groups were performed using independent two-sample t‑tests for continuous variables and Fisher’s exact test for categorical variables. No statistically significant differences were observed in age, sex, height, weight, marital status, tobacco use, comorbidities, or length of hospital stay between the two treatment groups (Table 1). Given the observational, cross‑sectional design of this study and the absence of significant between‑group differences in measured baseline covariates, no formal confounding adjustment methods (e.g., multivariable regression, propensity score matching, or inverse probability weighting) were applied. Consequently, the potential for residual confounding from unmeasured or imperfectly measured variables (e.g., fracture morphology, surgeon preference, socioeconomic status) remains. This limitation is explicitly addressed in the discussion section. Comparisons of baseline demographic and clinical characteristics between the plate fixation and intramedullary nailing groups were performed using independent two-sample t‑tests for continuous variables and Fisher’s exact test for categorical variables. No statistically significant differences were observed in age, sex, height, weight, marital status, tobacco use, comorbidities, or length of hospital stay between the two treatment groups (Table 1). Given the observational, cross‑sectional design of this study and the absence of significant between‑group differences in measured baseline covariates, no formal confounding adjustment methods (e.g., multivariable regression, propensity score matching, or inverse probability weighting) were applied. Consequently, the potential for residual confounding from unmeasured or imperfectly measured variables (e.g., fracture morphology, surgeon preference, socioeconomic status) remains. This limitation is explicitly addressed in the discussion section. QALY estimation Quality-adjusted life years (QALYs) were estimated using an integrated area-under-the-curve (AUC) approach based on repeated EQ-5D-5L utility measurements over the 3-month follow-up period. Health-related quality of life (HRQoL) was assessed at three predefined time points: the end of the first postoperative week (day 7), the sixth postoperative week (day 42), and the end of the third month (day 90). Utilities between consecutive measurements were assumed to change linearly, and QALYs were calculated by integrating the utility values over time using the trapezoidal rule. Specifically, the follow-up period was divided into three intervals (days 1–7, days 8–42, and days 43–90), and interval-specific QALYs were calculated by multiplying the mean utility over each interval by its corresponding duration (expressed in years). Total QALYs for each treatment strategy were obtained by summing interval-specific QALYs across the full 90-day horizon. Incremental QALYs were then calculated as the difference in total accumulated QALYs between intramedullary nailing and plate fixation. Due to the acute traumatic nature of tibial shaft fractures and the emergency presentation of patients, it was not feasible to measure pre‑injury or baseline health‑related quality of life (HRQoL) before the surgical intervention. Therefore, no baseline utility value was available for adjustment in QALY calculations. The analysis assumed that, in the absence of baseline differences in measured demographic and clinical characteristics (Table 1), the two treatment groups were comparable in terms of their pre‑injury HRQoL. Table 1Demographic characteristics of the study sampleVariablePlating (N = 69)Intramedullary nailing (N = 31)Total (N = 100)p-value Age (years) 30.71 ± 14.5133.77 ± 17.0631.66 ± 15.33*0.35 Height (cm) 172.68 ± 7.98175.64 ± 4.75173.60 ± 7.24*0.058 Weight (kg) 75.28 ± 17.5076.64 ± 8.8875.71 ± 15.31*0.068 Length of stay (days) 2.95 ± 2.252.41 ± 1.082.79 ± 1.97*0.210 Gender Male643094**0.292Female516 Marital status Single321850**0.097Married371350 Tobacco use Yes10717**0.134No592483 Comorbidities Yes314**0.414No663096*Independent two-sample t-test, **Fisher’s exact test Demographic characteristics of the study sample *Independent two-sample t-test, **Fisher’s exact test Cost and economic analysis The price year for all cost data was 2024 US dollars (USD). Costs originally recorded in Iranian Rial (IRR) were converted to USD using the World Bank DEC alternative conversion factor for 2024 (USD 1 = IRR 452,865), ensuring consistency with the stated price year and the willingness-to-pay threshold. Costs were analyzed from a modified societal perspective, including direct medical costs (captured from both hospital and patient records) and direct non-medical costs (captured from patient reports). Indirect costs, such as productivity losses, were not included because the short-term nature of tibial shaft fracture recovery in this study (three months) limits the potential impact of long-term productivity changes on overall cost-effectiveness. The primary economic outcome was the Incremental Cost-Effectiveness Ratio (ICER), calculated by comparing the incremental costs and effectiveness between intramedullary nailing and plate fixation. A willingness-to-pay (WTP) threshold was set at USD 4,771.4, based on Iran’s GDP per capita (current US$) for 2024, as reported by the World Bank. Direct non-medical costs—including travel, accommodation, and caregiver expenses—were collected through patient interviews at three months post-treatment; given the relatively short recall period, potential recall bias is expected to be minimal. In this study, strategies that were more costly and less effective—specifically, plate fixation—were classified as absolutely dominated, and ICERs were calculated only for the undominated strategy, intramedullary nailing. Statistical and sensitivity analysis All statistical and economic analyses were performed using Stata version 16 and TreeAge Pro 2020. Descriptive statistics were used to summarize baseline characteristics, costs, and outcomes. Economic uncertainty was assessed through deterministic one-way sensitivity analysis, presented as tornado diagrams, and probabilistic sensitivity analysis (PSA) using Monte Carlo simulation. In the PSA, cost parameters were modeled using gamma distributions, while health outcomes (QALYs) were modeled using normal distributions, with parameters based on observed means and standard deviations. Results of the PSA were summarized using cost-effectiveness scatterplots and cost-effectiveness acceptability curves (CEACs) across the predefined willingness-to-pay threshold. Results A total of 276 patients with tibial fractures were identified, of whom 167 did not meet the inclusion criteria. Accordingly, 107 patients were enrolled in the study; however, during the follow-up period, 7 patients were excluded due to requiring unwillingness to continue participation. Of the remaining 100 patients, 69 underwent plate fixation and 31 were treated with intramedullary nailing (Fig. 1). Flow diagram of the distribution of study samples into two groups Among the 100 patients included in the study, 94% were male and 50% were single. Additionally, 17% reported tobacco use, and only 4% had underlying comorbidities. Regarding continuous variables, the mean age ± standard deviation was 30.71 ± 14.51 years in both the plate fixation and intramedullary nailing groups, with no statistically significant difference (p = 0.35). Although the mean length of hospital stay was higher in the plate fixation group compared to the intramedullary nailing group, this difference did not reach statistical significance. Similarly, no significant differences were found between the two groups in terms of height and age (p > 0.05) (Table 1). Table 2 compares VAS scores, HRQoL, and accumulated QALYs between plate fixation and intramedullary nailing across three follow-up periods (week 1, week 6, and month 3). HRQoL was poor in both groups during the first postoperative week but improved progressively over time. At six weeks and three months, intramedullary nailing showed higher mean VAS and HRQoL values than plate fixation, although differences at individual time points were not statistically significant. Using a linear area-under-the-curve approach, total accumulated QALYs over 90 days were higher for intramedullary nailing (0.0627) compared with plate fixation (0.0448), indicating greater overall short-term health benefit despite similar point estimates at three months. Table 2Comparison of VAS, health-related quality of life, and accumulated QALYs across follow-up periodsFollow-up periodTreatment methodMean VAS (SD)Mean HRQOL (SD)Incremental QALYFirst week (Day 1 to 7)Plating20.35 ± 12.61-0.22 ± 0.18-0.0042Nailing24.28 ± 7.86-0.04 ± 0.15-0.0037Sixth week (Day 8 to 42)Plating39.61 ± 20.760.22 ± 0.140.0006Nailing45.83 ± 15.580.27 ± 0.160.0115Third month (Day 43 to 90)Plating63.45 ± 20.470.51 ± 0.190.0484Nailing70.0 ± 15.320.56 ± 0.120.0550(Day 1 to 90)Plating--0.0448Nailing-0.0627 Comparison of VAS, health-related quality of life, and accumulated QALYs across follow-up periods The total direct costs were higher in the plate fixation group, with a mean of USD 669.68, compared to USD 602.87 in the intramedullary nailing group. The largest share of these costs in both groups was hospital expenses: USD 472.84 in the plate fixation group and USD 448.47 in the intramedullary nailing group. Regarding direct non-medical costs, including accommodation, transportation, and meals, there was little difference between the two groups, with a total of USD 6.34 in the plate fixation group and USD 5.48 in the intramedullary nailing group (Table 3). Table 3Description of direct medical and non-medical costs in study patients by groupCost type (USD, 2024)Plating (N = 69)Intramedullary nailing (N = 31)Mean (USD)Standard deviationMean (USD)Standard deviationHospital costs472.84235.96448.47168.08Accommodation costs2.3010.402.145.99Transportation costs2.598.241.002.78Food costs1.446.542.356.03 Total direct non-medical costs 6.3422.025.4813.20Medical equipment and supplies costs24.3520.8026.4326.76Medication costs27.8331.8923.7224.69Visit costs25.7621.4820.0510.69Home care costs10.8250.17-*Other direct medical costs101.7475.7078.7162.41Total direct costs669.68300.35602.87182.69*Home care costs: Reported only if services were used; zero if not applicable Description of direct medical and non-medical costs in study patients by group *Home care costs: Reported only if services were used; zero if not applicable The cost-effectiveness analysis indicated that intramedullary nailing was the undominated strategy, with a total cost of USD 602.87 and an accumulated effectiveness of 0.0627 QALYs over the 90-day follow-up period. As the least costly and most effective option, intramedullary nailing was considered the reference strategy; therefore, no ICER was calculated for this treatment. Plate fixation was classified as absolutely dominated, as it incurred higher costs (USD 669.68) while yielding lower effectiveness (0.0448 QALYs) compared with intramedullary nailing (Table 4). Table 4Cost-effectiveness analysis (in USD)StrategyCost (USD)QALYs (0–90 days)Incremental costIncremental QALYsICER (USD/QALY)Intramedullary nailing602.870.062700NAPlate fixation669.680.0448+ 66.81−0.0179Dominated Cost-effectiveness analysis (in USD) Figure 2 presents the cost-effectiveness analysis comparing intramedullary nailing and plate fixation for tibial shaft fractures. Intramedullary nailing is represented by a blue triangle at coordinates (0.0627 QALYs, USD 602.87), reflecting higher effectiveness and lower total cost. Plate fixation, depicted as a red square with an overlaid yellow circle to indicate a dominated strategy, is positioned at (0.0448 QALYs, USD 669.68), showing lower effectiveness and higher cost relative to nailing. Cost-effectiveness plot comparing intramedullary nailing and plate fixation Figure 3 presents the tornado diagram illustrating the results of the one-way sensitivity analysis on incremental QALYs for intramedullary nailing compared with plate fixation. The diagram shows that the QALY for the nailing group (QALY_Nailing) is the most influential parameter, followed by the QALY for the plate fixation group (QALY_Plating), indicating that variations in health-related quality of life are the primary drivers of uncertainty in the effectiveness results. Across the tested parameter ranges, intramedullary nailing consistently remains the undominated strategy, with the base-case incremental QALY of 0.0179 favoring nailing. Overall, the tornado diagram highlights that short-term effectiveness (QALY gains) is the main source of variability in the model, while cost inputs were evaluated separately in the cost analysis. Tornado diagram for sensitivity analysis of model inputs Figure 4 presents the results of the probabilistic sensitivity analysis based on Monte Carlo simulation at willingness-to-pay (WTP) threshold of USD 4,771.4 per QALY, corresponding to Iran’s 2024 GDP per capita. The analysis compares intramedullary nailing and plate fixation in terms of cost-effectiveness uncertainty. Across simulations, intramedullary nailing was identified as the cost-effective strategy in approximately 65% of iterations, while plate fixation was optimal in 35% of simulations. Monte Carlo acceptability curve at willingness-to-pay threshold Figure 5 illustrates the cost-effectiveness acceptability curve (CEAC) based on probabilistic sensitivity analysis. At the predefined willingness-to-pay threshold of 4,771.4, intramedullary nailing shows a higher probability of being cost-effective (approximately 0.65–0.68) compared with plate fixation (approximately 0.32–0.35). As the WTP increases, the probability of cost-effectiveness for nailing increases, while that for plate fixation declines. Overall, the CEAC indicates that intramedullary nailing is more likely to be the cost-effective strategy at the selected WTP threshold, supporting the robustness of the base-case findings under uncertainty. Cost-effectiveness acceptability curve for plate fixation and intramedullary nailing Figure 6 presents the cost-effectiveness scatterplot generated from the probabilistic sensitivity analysis, displaying the joint distribution of costs and health outcomes (QALYs) for plate fixation and intramedullary nailing. The scatterplot demonstrates that intramedullary nailing is generally associated with higher QALYs and lower costs compared with plate fixation, with most simulations located in the south-east quadrant of the cost-effectiveness plane relative to plate fixation. In contrast, plate fixation shows lower effectiveness and higher costs across the majority of simulations. The limited overlap between the two distributions indicates a consistent economic advantage of intramedullary nailing under parameter uncertainty. Cost-effectiveness scatterplot of plate fixation versus intramedullary nailing Discussion This study assessed health-related quality of life (HRQoL) in patients with tibial shaft fractures and showed that, over the 90-day follow-up period, patients treated with intramedullary nailing accrued higher total quality-adjusted life years (QALYs) than those treated with plate fixation, based on an area-under-the-curve approach using repeated HRQoL measurements. Although differences at individual follow-up time points were not statistically significant, the accumulated QALYs favored intramedullary nailing. These findings are consistent with Kang et al. (2021), who reported comparable functional and radiological outcomes for both methods, as well as Maredza et al. (2018), who found no significant difference in HRQoL between the two groups at 12 months post-surgery [30]. Before interpreting this QALY difference as a treatment effect, it is important to consider that pre‑injury (baseline) health‑related quality of life was not measured in this study, due to the emergency nature of trauma admissions. Therefore, the observed difference in accumulated QALYs between the two groups may partly reflect unmeasured differences in pre‑injury health status rather than the true differential effectiveness of the two surgical techniques. The direction of potential bias is uncertain but can be hypothesised: if patients in the plate fixation group had systematically lower pre‑injury HRQoL (e.g., due to unmeasured factors such as more physically demanding occupations, lower baseline functional status, or pre‑existing knee/ankle problems), then the higher QALYs observed in the nailing group could be overestimated relative to the true treatment effect. Conversely, if the nailing group had lower pre‑injury HRQoL, the true benefit of nailing would be underestimated by our findings. Given the absence of baseline utility data, the reported QALY difference of 0.0179 over 90 days should be interpreted as an association rather than a causal estimate. A randomised controlled trial or an observational study with baseline HRQoL measurement (e.g., using a recall instrument or immediate pre‑operative assessment) would be required to confirm whether the observed difference is genuinely attributable to the choice of implant. Total direct costs were higher in the plate fixation group (USD 669.68) than in the intramedullary nailing group (USD 602.87). When combined with higher accumulated QALYs over the 90-day follow-up, intramedullary nailing was identified as the undominated and more cost-effective strategy. This aligns with findings from Maredza and Köksal, who reported significantly higher costs associated with plating and identified nailing as the more economical option [16, 30]. Köksal specifically noted that nailing reduced intervention costs by approximately USD 288.30 compared to plating for extra-articular distal tibia fractures, from admission through discharge [16]. Our cost-effectiveness analysis consistently identified intramedullary nailing as the undominated and economically favorable treatment strategy over the 90-day follow-up period. Intramedullary nailing was associated with lower total direct costs (USD 602.87) and higher accumulated effectiveness (0.0627 QALYs) compared with plate fixation (USD 669.68 and 0.0448 QALYs, respectively), leading to the classification of plate fixation as absolutely dominated. Accordingly, no ICER was calculated for the dominated strategy, in line with standard economic evaluation practice. These findings are broadly consistent with international evidence supporting the economic advantage of intramedullary nailing. For instance, the UK FixDT trial–based economic evaluation by Maredza et al. demonstrated that intramedullary nailing reduced overall costs while maintaining or improving health outcomes, largely driven by earlier return to work and lower productivity losses [30]. In contrast to FixDT, the present study did not collect indirect cost components such as sick leave duration or time to return to work. As a result, our analysis was conducted from a modified societal perspective limited to direct medical and direct non-medical costs. This limitation may underestimate the full economic advantage of intramedullary nailing and restrict direct comparability with studies adopting a full societal perspective. Additionally, Roberts et al. (2021) reported in Tanzania that nailing was more cost-effective than alternatives like external fixation and contributed to reducing overall healthcare costs despite differing demographic and healthcare contexts [31]. The alignment of these results with our study suggests the economic superiority of nailing extends across diverse healthcare settings. Strengths and constraints of the study This study has several notable strengths as well as important limitations. Among its strengths, the comprehensive assessment of direct medical costs (including both hospital and outpatient expenditures) and direct non-medical costs (such as transportation, accommodation, and meals) allowed for a broad societal-perspective evaluation. The use of actual hospital information system (HIS) records improved the accuracy of cost estimates and increased the applicability of findings to real-world clinical practice. Despite these strengths, the study has several methodological limitations. First, the relatively small sample size and imbalance between treatment groups—reflecting real-world clinical decision-making and the limited pool of eligible patients—may introduce selection bias and reduce statistical power. Second, the follow-up duration was restricted to three months, capturing only the early postoperative recovery phase; consequently, the analysis could not account for long-term outcomes such as fracture union, malunion, nonunion, deep infection, or reoperations, which are key drivers of costs and HRQoL. No extrapolation or extended model structure beyond three months was implemented. Third, although QALYs were derived using the area-under-the-curve approach across the three follow-up time points, only short-term utility measurements were available, which may limit precision and increase uncertainty. In addition, baseline pre-treatment HRQoL data were not available, as utility measurements commenced during the postoperative follow-up period. Consequently, the observed QALY differences between groups may partly reflect unmeasured baseline differences in patient health status, functional capacity, or fracture severity rather than treatment effects alone. Fourth, fracture morphology data—including AO/OTA classification, comminution, fibula involvement, and segment location—were not fully documented for all patients, potentially introducing confounding by fracture characteristics. Fifth, given the observational design, no formal statistical adjustment for potential confounding (e.g., multivariable regression or propensity score methods) was performed. Baseline characteristics of the two treatment groups were examined and found to be generally similar, including age, sex, comorbidities, smoking status, marital status, and hospital length of stay. Nevertheless, residual confounding cannot be entirely ruled out, and differences in patient characteristics, fracture morphology, or other unmeasured factors may have influenced both costs and health outcomes. Finally, indirect costs such as productivity loss were not captured, potentially underestimating the full societal burden. Non-medical cost components (e.g., transportation, meals, accommodation) were collected via patient self-report and may be subject to recall bias. Conclusion Overall, these findings underscore the value of incorporating robust cost-effectiveness evidence into clinical and health-system decision-making. Within a short-term (90-day) horizon and from a modified societal perspective, intramedullary nailing emerged as an undominated strategy, providing higher short-term health benefits (QALYs) at lower direct costs compared with plate fixation. While longer-term outcomes and indirect costs were not captured, the results support the preferential use of intramedullary nailing for tibial shaft fractures in similar settings. From a policy and management perspective, these findings highlight the importance of aligning clinical practice with economic evidence through targeted surgeon training, systematic monitoring of costs and outcomes, optimization of perioperative and rehabilitation pathways, and informed resource allocation to improve efficiency and patient-centered outcomes. Acknowledgements The authors would like to thank the staff of Shahid Dr. Rahnemoon Hospital and the Trauma Research Center of Shahid Sadoughi University of Medical Sciences for their valuable support in data collection and patient follow-up. We are also grateful to all the patients who generously participated in this study. Abbreviations Health-related quality of life Visual analogue scale Incremental cost-effectiveness ratio Quality-adjusted life years Gross domestic product Cost-effectiveness ratio Willingness to pay Author contributions A.M. s contributed to study design, data collection, and drafting the manuscript. M. R played a central role in study design, data analysis, interpretation, and contributed significantly to most sections of the manuscript. S.H.S provided clinical expertise and supervised data collection in the orthopedic department. R. D advised on economic analysis and interpretation. S.M. M and M. R contributed to data analysis, critical revisions, and final approval of the manuscript. All authors reviewed and approved the final version. Funding This study was part of a Master’s thesis in Health Economics at Shahid Sadoughi University of Medical Sciences, Yazd, Iran, and was financially supported by the university. Data availability The data-sets used and/or analyzed during the current study available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate The present study was conducted in accordance with the principles of the revised Declaration of Helsinki. Ethical approval was obtained from the Research Ethics Committee of the School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd (IR.SSU.SPH.REC.1403.029) prior to study initiation. All patients received care according to standard hospital protocols as determined by their treating surgeons. The researcher had no role in treatment allocation, and patient assignment was based solely on clinical judgment. Prior to enrollment, patients were informed about the potential outcomes of both treatment methods, and written informed consent was obtained from all participants. Patient data were handled confidentially, and all analyses were conducted on anonymized datasets in accordance with the approved ethical procedures. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The data-sets used and/or analyzed during the current study available from the corresponding author on reasonable request.